Imunologi imunologis Terbaik di Israel - TOP-15 dokter

Dr. Grisaro Galia memimpin layanan Penyakit Menular Anak di Rumah Sakit Anak Dana-Dwek – mengkhususkan diri secara eksklusif pada kasus anak.

• Peran tingkat direktur di rumah sakit anak terkemuka
• Menempuh pendidikan di University of Toronto – pemimpin global dalam penelitian penyakit menular
• Memiliki gelar Marze Bachir dalam penyakit menular anak
• Berfokus pada kasus infeksi anak yang kompleks

Dr. Katsman berspesialisasi dalam perawatan HIV di Sourasky Medical Center, dengan pengalaman lebih dari 25 tahun dalam penyakit menular.

• Staf dokter senior di Tel Aviv Sourasky Medical Center
• Pelatihan lanjutan di McGill AIDS Centre di Montreal
• Anggota International AIDS Society dan European AIDS Clinical Society
• Berafiliasi dengan The Crusaid Kobler AIDS Center

Profesor Eli Sprecher memimpin Departemen Dermatologi di Sourasky Medical Center Tel Aviv, dengan fokus pada penyakit kulit genetik.

• Spesialisasi dalam genetika dermatologis di Thomas Jefferson University
• Menulis lebih dari 220 publikasi ilmiah di bidang dermatologi
• Anggota masyarakat kunci termasuk American Academy of Dermatology
• Jabatan profesor di Technion – Israel Institute of Technology

Tercantum dalam daftar dokter terbaik Israel versi Forbes tahun 2021, Prof. Kivity adalah spesialis alergi dan imunologi di Sourasky Medical Center.

• Ahli dalam mendiagnosis dan mengobati alergi, asma, dan rinitis alergi
• Anggota dari berbagai perhimpunan alergi dan imunologi internasional
• Menempuh pendidikan di institusi bergengsi termasuk National Jewish Hospital
• Penerima berbagai penghargaan penelitian di bidang imunologi

Kepala reumatologi di Sourasky Medical Center – Dr. Kaspy berspesialisasi dalam kasus-kasus kompleks dan memimpin program spesialisasi reumatologi Israel.

• Menyelesaikan magang bergengsi di Hammersmith Hospital di London
• Mantan Kepala rumah sakit harian reumatologi di Ichilov
• 140+ publikasi ilmiah tentang reumatologi
• Anggota Asosiasi Reumatologi Israel dan Amerika

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Memimpin Departemen Hematologi di Pusat Medis Hadassah, Prof. Dina Ben-Yehuda mengintegrasikan imunologi dan terapi gen mutakhir untuk penyakit darah.

• Profesor dengan pengalaman 25+ tahun di bidang hematologi dan imunologi
• Pelopor dalam transplantasi sumsum tulang dan terapi gen
• Menempuh pendidikan di Memorial Sloan-Kettering Cancer Center di New York
• Dekan wanita pertama di Fakultas Kedokteran Hadassah
• Penerima berbagai penghargaan bergengsi untuk perawatan pasien

Dr. Dimitrios Karussis memimpin Klinik Multiple Sclerosis multidisiplin di Hadassah Medical Center dengan pengalaman 30+ tahun di bidang neuroimunologi.

• Spesialisasi dalam neuroimunologi dan transplantasi sumsum tulang
• Kepala Laboratorium EAE di Hadassah
• Anggota 'Steering Committee' Eropa untuk Transplantasi Sumsum Tulang
• PhD dalam Neuroimunologi/Neurobiologi

Dr. Michael Lotem memimpin Pusat Imunoterapi Melanoma dan Kanker di Hadassah Medical Center, merintis pengobatan baru untuk melanoma.

• Spesialisasi dalam imunoterapi untuk pengobatan kanker
• Mempelajari reseptor SLAM dalam respons imun anti-kanker
• Menggabungkan praktik klinis dengan penelitian translasi
• Tim terdiri dari dokter klinis dan peneliti papan atas